Detailed TOC of Global Veterinary Pharmaceutical Drug Market Research Report 2024
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Pharmaceutical Drug Market Size Growth Rate by Type: 2019 VS 2024 VS 2032
1.2.2 Oral
1.2.3 Injection
1.2.4 Other
1.3 Market by Application
1.3.1 Global Veterinary Pharmaceutical Drug Market Growth by Application: 2019 VS 2024 VS 2032
1.3.2 Companion Animals
1.3.3 Livestock Animals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Pharmaceutical Drug Market Perspective (2019-2032)
2.2 Veterinary Pharmaceutical Drug Growth Trends by Region
2.2.1 Global Veterinary Pharmaceutical Drug Market Size by Region: 2019 VS 2024 VS 2032
2.2.2 Veterinary Pharmaceutical Drug Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Pharmaceutical Drug Forecasted Market Size by Region (2025-2032)
2.3 Veterinary Pharmaceutical Drug Market Dynamics
2.3.1 Veterinary Pharmaceutical Drug Industry Trends
2.3.2 Veterinary Pharmaceutical Drug Market Drivers
2.3.3 Veterinary Pharmaceutical Drug Market Challenges
2.3.4 Veterinary Pharmaceutical Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Pharmaceutical Drug Players by Revenue
3.1.1 Global Top Veterinary Pharmaceutical Drug Players by Revenue (2019-2024)
3.1.2 Global Veterinary Pharmaceutical Drug Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Pharmaceutical Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Pharmaceutical Drug Revenue
3.4 Global Veterinary Pharmaceutical Drug Market Concentration Ratio
3.4.1 Global Veterinary Pharmaceutical Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Pharmaceutical Drug Revenue in 2024
3.5 Veterinary Pharmaceutical Drug Key Players Head office and Area Served
3.6 Key Players Veterinary Pharmaceutical Drug Product Solution and Service
3.7 Date of Enter into Veterinary Pharmaceutical Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Pharmaceutical Drug Breakdown Data by Type
4.1 Global Veterinary Pharmaceutical Drug Historic Market Size by Type (2019-2024)
4.2 Global Veterinary Pharmaceutical Drug Forecasted Market Size by Type (2025-2032)
5 Veterinary Pharmaceutical Drug Breakdown Data by Application
5.1 Global Veterinary Pharmaceutical Drug Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Pharmaceutical Drug Forecasted Market Size by Application (2025-2032)
6 North America
6.1 North America Veterinary Pharmaceutical Drug Market Size (2019-2032)
6.2 North America Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2024 VS 2032
6.3 North America Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
6.4 North America Veterinary Pharmaceutical Drug Market Size by Country (2025-2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Pharmaceutical Drug Market Size (2019-2032)
7.2 Europe Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2024 VS 2032
7.3 Europe Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
7.4 Europe Veterinary Pharmaceutical Drug Market Size by Country (2025-2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Pharmaceutical Drug Market Size (2019-2032)
8.2 Asia-Pacific Veterinary Pharmaceutical Drug Market Growth Rate by Region: 2019 VS 2024 VS 2032
8.3 Asia-Pacific Veterinary Pharmaceutical Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Pharmaceutical Drug Market Size by Region (2025-2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Pharmaceutical Drug Market Size (2019-2032)
9.2 Latin America Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2024 VS 2032
9.3 Latin America Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
9.4 Latin America Veterinary Pharmaceutical Drug Market Size by Country (2025-2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Pharmaceutical Drug Market Size (2019-2032)
10.2 Middle East & Africa Veterinary Pharmaceutical Drug Market Growth Rate by Country: 2019 VS 2024 VS 2032
10.3 Middle East & Africa Veterinary Pharmaceutical Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Pharmaceutical Drug Market Size by Country (2025-2032)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Veterinary Pharmaceutical Drug Introduction
11.1.4 Boehringer Ingelheim Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Veterinary Pharmaceutical Drug Introduction
11.2.4 Zoetis Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.2.5 Zoetis Recent Development
11.3 Elanco Animal Health
11.3.1 Elanco Animal Health Company Detail
11.3.2 Elanco Animal Health Business Overview
11.3.3 Elanco Animal Health Veterinary Pharmaceutical Drug Introduction
11.3.4 Elanco Animal Health Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.3.5 Elanco Animal Health Recent Development
11.4 Merck Animal Health
11.4.1 Merck Animal Health Company Detail
11.4.2 Merck Animal Health Business Overview
11.4.3 Merck Animal Health Veterinary Pharmaceutical Drug Introduction
11.4.4 Merck Animal Health Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.4.5 Merck Animal Health Recent Development
11.5 Virbac
11.5.1 Virbac Company Detail
11.5.2 Virbac Business Overview
11.5.3 Virbac Veterinary Pharmaceutical Drug Introduction
11.5.4 Virbac Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Detail
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Veterinary Pharmaceutical Drug Introduction
11.6.4 Dechra Veterinary Products Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva
11.7.1 Ceva Company Detail
11.7.2 Ceva Business Overview
11.7.3 Ceva Veterinary Pharmaceutical Drug Introduction
11.7.4 Ceva Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.7.5 Ceva Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Detail
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Veterinary Pharmaceutical Drug Introduction
11.8.4 Vetoquinol Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.8.5 Vetoquinol Recent Development
11.9 Meiji
11.9.1 Meiji Company Detail
11.9.2 Meiji Business Overview
11.9.3 Meiji Veterinary Pharmaceutical Drug Introduction
11.9.4 Meiji Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.9.5 Meiji Recent Development
11.10 Ouro Fino Saude
11.10.1 Ouro Fino Saude Company Detail
11.10.2 Ouro Fino Saude Business Overview
11.10.3 Ouro Fino Saude Veterinary Pharmaceutical Drug Introduction
11.10.4 Ouro Fino Saude Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.10.5 Ouro Fino Saude Recent Development
11.11 Animalcare Group
11.11.1 Animalcare Group Company Detail
11.11.2 Animalcare Group Business Overview
11.11.3 Animalcare Group Veterinary Pharmaceutical Drug Introduction
11.11.4 Animalcare Group Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.11.5 Animalcare Group Recent Development
11.12 Parnell
11.12.1 Parnell Company Detail
11.12.2 Parnell Business Overview
11.12.3 Parnell Veterinary Pharmaceutical Drug Introduction
11.12.4 Parnell Revenue in Veterinary Pharmaceutical Drug Business (2019-2024)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
